Senti Bio Announces Third Quarter 2024 Results and Recent Pipeline and Corporate Highlights
Provided By GlobeNewswire
Last update: Nov 14, 2024
SOUTH SAN FRANCISCO, Calif., Nov. 14, 2024 (GLOBE NEWSWIRE) -- Senti Biosciences, Inc. (Nasdaq: SNTI) (“Senti Bio” or the “Company”), a biotechnology company developing next-generation cell and gene therapies using its proprietary Gene Circuit platform, today reported financial results for the third quarter of 2024 and provided a summary of recent pipeline and corporate highlights.
Read more at globenewswire.com3.17
-0.47 (-12.91%)
Find more stocks in the Stock Screener
SNTI Latest News and Analysis
16 hours ago - ChartmillIn today's session, these stocks are experiencing unusual volume.Let's have a look at the stocks with an unusual volume in today's session.
